the Diagnosis and Treatment of Familial Mediterranean Fever during Childhood and Adolescence
- References
1. Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol2014;10:135-47.
2. Yenokyan G, Armenian HK. Triggers for attacks in familial Mediterranean fever: application of the case-crossover design. Am J Epidemiol 2012;175:1054-61.
3. Fujikura K.Global epidemiology of Familial Mediterranean fever mutations using population exome sequences. Molecular Genetics & Genomic Medicine. 2015; 3(4): 272–282.
4. Berkun Y, Eisenstein E, Ben-Chetrit E. FMF – clinical features, new treatments and the role of genetic modifiers: a critical digest of the 2010–2012 literature. Clin Exp Rheumatol. 2012;30 Suppl.72:S90–5.
5. Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017; 36: 1707–13.
6. Çakan M, Karadağ SG, Tanatar A, Sönmez HE, and Ayaz NA. The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods. J Clin Rheumatol. 2021 Jan 1;27(1):1-4. doi: 10.1097/RHU.0000000000001134.
7. Ozdogan H, Ugurlu S. Familial Mediterranean Fever.Presse Med. 2019 Feb;48(1 Pt 2):e61-e76. doi: 10.1016/j.lpm.2018.08.014.
8. Chae, J. J., Y. H. Cho, G. S. Lee, J. Cheng, P. P. Liu, L. Feigenbaum, et al. 2011. Gain-of-functionpyrinmutationsinduce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity 34: 755– 768.
9. Hala S. Talaat, Maha F. Sheba, Rehab H. Mohammed, Mohamed Ali Gomaa, Nihal El Rifaei. Genotype Mutations in EgyptianChildrenwithFamilialMediterranean Fever: ClinicalProfile, and Response to Colchicine. Mediterr J Rheumatol. 2020 Jun; 31(2): 206–213.
10. Ozturk C, Halicioglu O, Coker I, Gulez N, Sutçuoglu S, Karaca N, et al. Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey. Clin Rheumatol. 2012; 31:493–501.
11. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 2009; 60(6):1862–6.
12. Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M et al. Evaluation of co-existing diseases in children with familial Mediterranean fever. Rheumatol Int. 2020; 40(1): 57-64.
13. Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı Z S, Avcı E, Akkaya-Ulum Z Y et al. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology, 2020; 59(6):1372-80.
14. Hashkes P J. 50 Years Ago in The Journal of Pediatrics: Amyloidosis in Childhood. J Pediatr, 2019; 205: 54
15. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A et al. International Study Group for PhenotypeGenotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum, 2007; 56(5): 1706-12.)
16. Cerquaglia C, Diaco M, Nucera G, La Regina M, Montalto M, Manna R. Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues: an update. Curr Drug Targets Inflamm Allergy 2005;4(1):117-24.
17. Ben-Chetrit E, Bergmann S, Sood R. Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology (Oxford) 2006;45(3):274-82.
18. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 2016;75(4):644-51.
19. Haimov-Kochman R, Ben-Chetrit E. The effect of colchicine treatment on sperm production and function: a review. Hum Reprod 1998;13(2):360-2.
20. Erdem E, Karatas A, Kaya C, et al Renal transplantation in patients with familial Mediterranean fever. Clin Rheumatol 2012;31:1183–6.
21. Dinarello CA, Simon A, Van derMeer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov2012;11(8):633-52.
22. Keven K, Sengul S, Kutlay S, Ekmekci Y, AnadoletEal Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc 2004; 36:2632–4.
23. Amital H, Ben-Chetrit E. Therapeutic approaches to familial Mediterranean fever. What do we know and where are we going to? Clin Exp Rheumatol 2004;22(Suppl 34):S4–7.
24. Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaet F al. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 2011;41:265–71.
25. TerreriM, Bernardo W, Len C, Artur C, Ribeiro C et al. Guidelines for the management and treatment of periodic fever syndromes familial Mediterranean fever. rev bras reumatol. 2016;5 6(1):37–43
26. Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Çakar N et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009; 48:395–8.
27. Giancane, G., N. M. Ter Haar, N. Wulffraat, S. J. Vastert, K. Barron, V. Hentgen, et al. 2015. Evidence-basedrecommendations for geneticdiagnosisoffamilialMediterraneanfever. Ann. Rheum. Dis.74:635–41.
28. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016; 75(4):644–51.
29. Amer YS, Elzalabany MM, Omar TI, Ibrahim AG, Dowidar NL. The 'Adapted ADAPTE': an approach to improve utilization of the ADAPTE guideline adaptation resource toolkit in the Alexandria Center for Evidence-Based Clinical Practice Guidelines. J Eval Clin Pract. 2015 Dec;21(6):1095-106
30. Schünemann H, Brozek J, Guyatt G, Oxman A (editors). GRADE handbook: handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group; 2013 (Online updated version: https://gdt.gradepro.org/app/handbook/handbook.html Accessed 16/8/2024)
31. Agree II (2022) AGREE Enterprise website. Available at: https://www.agreetrust.org/resource-centre/agree-ii/.
32. Song Y, Alonso-Coello P, Ballesteros M, et al. A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist[J]. Annals of Internal Medicine, 2022, 175(5):710-719. https://doi.org/10.7326/M21-4352(Official RIGHT Statement Website: http://www.right-statement.org/extensions/13 Accessed 16/8/2024)